Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters











Database
Language
Publication year range
1.
Rev Soc Bras Med Trop ; 56: e0513, 2023.
Article in English | MEDLINE | ID: mdl-37075453

ABSTRACT

BACKGROUND: Bacterial resistance to extended-spectrum beta-lactamases (ESBL) is present worldwide. Empirical antibiotic therapy is often needed, and the use of fluoroquinolones, such as ciprofloxacin and norfloxacin, is common. This study aimed to analyze the urine cultures from 2,680 outpatients in January 2019, 2020, 2021, and 2022, with bacterial counts above 100,000 CFU/mL in which Escherichia coli was the etiological agent. METHODS: We monitored the resistance of ESBL-positive and ESBL-negative strains to ciprofloxacin and norfloxacin and evaluated resistance rates. RESULTS: Significantly higher fluoroquinolone resistance rates were observed among ESBL-positive strains in all years studied. Furthermore, a significant increase in the rate of fluoroquinolone resistance was observed between 2021 and 2022 in ESBL-positive and -negative strains, as well as from 2020 to 2021 among the ESBL-positive strains. CONCLUSIONS: The data obtained in the present study showed a tendency towards an increase in fluoroquinolone resistance among ESBL-positive and -negative E. coli strains isolated from urine cultures in Brazil. Since empirical antibiotic therapy with fluoroquinolones is commonly used to treat diverse types of infections, such as community-acquired urinary tract infections, this work highlights the need for continuous monitoring of fluoroquinolone resistance among E. coli strains circulating in the community, which can mitigate the frequency of therapeutic failures and development of widespread multidrug-resistant strains.


Subject(s)
Community-Acquired Infections , Escherichia coli Infections , Urinary Tract Infections , Humans , Fluoroquinolones/pharmacology , Escherichia coli , Escherichia coli Infections/drug therapy , Escherichia coli Infections/microbiology , Norfloxacin , beta-Lactamases , Urinary Tract Infections/drug therapy , Urinary Tract Infections/microbiology , Ciprofloxacin , Community-Acquired Infections/drug therapy , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/therapeutic use , Microbial Sensitivity Tests
3.
Microbes Infect ; 24(8): 105001, 2022.
Article in English | MEDLINE | ID: mdl-35569750

ABSTRACT

For many years, the potential pathogenic of non-diphtheriae corynebacteria were underestimated. Nowadays, a growing number of Corynebacterium species are recognized as opportunistic agents of human infections, mainly in hospital settings. In addition, multidrug-resistant Corynebacterium isolates from clinical specimens, have been reported and the role of Corynebacterium spp. in urinary tract infections (UTIs) has been highlighted. Several studies have reported Corynebacterium species as the agent of UTIs especially in patients with risk factors. Thus, the present work aimed to report the first isolation of Corynebacterium mycetoides from human urine and an initial study on its virulence properties. The isolate, initially characterized by phenotypical tests as a multidrug-resistant Corynebacterium sp., was recovered from the urine of a female transplant patient. Mass spectrometry and 16S rRNA and rpoB genes sequencing identified the isolate as C. mycetoides. The isolate was found able to adhere to and survive into epithelial cells (Vero cells), and its pathogenic potential was confirmed when tested against Caenorhabditis elegans nematode. The results obtained suggest that C. mycetoides is a potential pathogen for the urinary tract in humans and for a better understanding of the multifactorial mechanisms of virulence, studies about this species should be continued.


Subject(s)
Corynebacterium Infections , Urinary Tract Infections , Animals , Chlorocebus aethiops , Humans , Female , Corynebacterium Infections/microbiology , Virulence , RNA, Ribosomal, 16S/genetics , Vero Cells , Corynebacterium/genetics
6.
Microb Drug Resist ; 26(12): 1546-1558, 2020 Dec.
Article in English | MEDLINE | ID: mdl-32429830

ABSTRACT

Disinfection and antisepsis are of primary importance in controlling nosocomial infections and outbreaks by pathogens expressing multiple resistance to antimicrobial agents (multidrug-resistant [MDR]) used in therapy. Nowadays, infections related to health services (HAIs) due to MDR and multidrug-susceptible (MDS) Corynebacterium striatum should not be underestimated, including patients using invasive medical devices. The virulence potential of C. striatum needs further investigation. Currently, susceptibility profiles of planktonic and/or sessile forms of four C. striatum strains of different pulsed-field gel electrophoresis types were examined as biocides based on the manufacturer's recommendations: 2% glutaraldehyde (GA), 2% peracetic acid (PA), 1% potassium monopersulfate (Virkon®; VK), 1% sodium hypochlorite (SH), and 70% ethyl alcohol (ET). Time-kill assays using 2% bovine serum albumin (BSA) were performed for evaluation of influence of organic matter on biocides effects. Planktonic forms expressed GA resistance at different levels. C. striatum viability was observed until 2, 4, 20, and 30 min for MDR 2369/II, MDS 1954/IV, MDR 1987/I, and MDS 1961/III strains, respectively. In contrast to GA, the biocides PA, VK24h, SH, and ET had higher effective bacterial mortality. However, storage of VK (48 hr) reduced their biocide activities. Moreover, mature biofilms were produced on abiotic substrates, including steel surfaces. Post-treatment with GA (30 min), survival of sessile forms was ≥100% than planktonic forms of all C. striatum tested strains. Independent of biocides tested, BSA increased the survival of planktonic and sessile forms (p ≤ 0.005). Present data indicated that hospital staff should be aware of dissemination and eradication of HAIs by C. striatum presenting resistance to biocides, including high-level disinfectants, such as GA.


Subject(s)
Anti-Infective Agents, Local/pharmacology , Biofilms/drug effects , Corynebacterium/drug effects , Disinfectants/pharmacology , Drug Resistance, Multiple, Bacterial , Plankton/drug effects , Adult , Cross Infection/prevention & control , Electrophoresis, Gel, Pulsed-Field , Female , Humans , Male , Microbial Sensitivity Tests , Middle Aged , Virulence
7.
Antonie Van Leeuwenhoek ; 108(5): 1275-9, 2015 Nov.
Article in English | MEDLINE | ID: mdl-26459339

ABSTRACT

Corynebacterium diphtheriae strains continue to circulate worldwide causing diphtheria and invasive diseases, such as endocarditis, osteomyelitis, pneumonia and catheter-related infections. Presumptive C. diphtheriae infections diagnosis in a clinical microbiology laboratory requires a primary isolation consisting of a bacterial culture on blood agar and agar containing tellurite (TeO3(2-)). In this study, nine genome sequenced and four unsequenced strains of C. diphtheriae from different sources, including three samples from a recent outbreak in Brazil, were characterized with respect to their growth properties on tellurite-containing agar. Levels of tellurite-resistance (Te(R)) were evaluated by determining the minimum inhibitory concentrations of potassium tellurite (K2TeO3) and by a viability reduction test in solid culture medium with K2TeO3. Significant differences in Te(R) levels of C. diphtheriae strains were observed independent of origin, biovar or presence of the tox gene. Data indicated that the standard initial screening with TeO3(2-)-selective medium for diphtheria bacilli identification may lead to false-negative results in C. diphtheriae diagnosis laboratories.


Subject(s)
Anti-Bacterial Agents/pharmacology , Corynebacterium diphtheriae/drug effects , Diphtheria/diagnosis , Diphtheria/microbiology , Drug Resistance, Bacterial , Tellurium/pharmacology , Bacterial Proteins/genetics , Corynebacterium diphtheriae/classification , Corynebacterium diphtheriae/genetics , Drug Resistance, Bacterial/genetics , Humans , Microbial Sensitivity Tests , Phylogeny , Virulence Factors/genetics
8.
Mem Inst Oswaldo Cruz ; 110(2): 242-8, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25946249

ABSTRACT

Corynebacterium striatum is a potentially pathogenic microorganism that causes nosocomial outbreaks. However, little is known about its virulence factors that may contribute to healthcare-associated infections (HAIs). We investigated the biofilm production on abiotic surfaces of multidrug-resistant (MDR) and multidrug-susceptible (MDS) strains of C. striatum of pulsed-field gel electrophoresis types I-MDR, II-MDR, III-MDS and IV-MDS isolated during a nosocomial outbreak in Rio de Janeiro, Brazil. The results showed that C. striatum was able to adhere to hydrophilic and hydrophobic abiotic surfaces. The C. striatum 1987/I-MDR strain, predominantly isolated from patients undergoing endotracheal intubation procedures, showed the greatest ability to adhere to all surfaces. C. striatum bound fibrinogen to its surface, which contributed to biofilm formation. Scanning electron microscopy showed the production of mature biofilms on polyurethane catheters by all pulsotypes. In conclusion, biofilm production may contribute to the establishment of HAIs caused by C. striatum.


Subject(s)
Biofilms/drug effects , Catheter-Related Infections/microbiology , Corynebacterium Infections/microbiology , Corynebacterium/physiology , Cross Infection/microbiology , Disease Outbreaks , Drug Resistance, Multiple, Bacterial , Adult , Anti-Bacterial Agents/pharmacology , Bacterial Adhesion/physiology , Brazil/epidemiology , Catheter-Related Infections/epidemiology , Corynebacterium/classification , Corynebacterium/ultrastructure , Corynebacterium Infections/epidemiology , Cross Infection/epidemiology , Electrophoresis, Gel, Pulsed-Field , Equipment and Supplies , Female , Fibrinogen/pharmacology , Glass , Humans , Male , Microscopy, Electron, Scanning , Middle Aged , Polyurethanes , Virulence Factors
SELECTION OF CITATIONS
SEARCH DETAIL